(May 28, 2020, 2:30 PM EDT) -- PHILADELPHIA — A Pennsylvania federal judge on May 26 said plaintiffs’ claims that generic drug manufacturer Sandoz Inc. failed to warn a patient about the pulmonary toxicity of the heart drug...
Judge: Learned Intermediary Preempts Claim Patient Wasn’t Warned Of Drug Risk
To view the full article, register now.
Try for FREE for fourteen days
Already a subscriber? Click here to login